
Dr. Michael Tirgan, MD
Oncologist
616.6 mi · 23 W 73rd St, Ste GD, New York, NY 10023
At a glance
Has 20+ years of experience
Graduated from Tehran University of Medical Sciences School of Medicine, Doctor of Medicine
Works at Michael H Tirgan, MD
2 office locations
Affiliated with Mount Sinai St. Luke’s
and Mount Sinai Roosevelt
Speaks English
Michael Tirgan does not participate in Zocdoc to offer online booking at this time
Similar providers on Zocdoc
Top-rated
Closest to you
Available today

Dr. Steven Gruenstein, MD
Oncologist
4.80203 reviews
1 mi12 E 86th St, New York, NY, 10028
Â
4.80203 reviews
1 mi12 E 86th St, New York, NY, 10028
Â

Dr. Gardith Joseph, MD
Oncologist
11.5 mi5202 Avenue N, Brooklyn, NY, 11234
Next available: Apr 2Offers telehealth
11.5 mi5202 Avenue N, Brooklyn, NY, 11234
Next available: Apr 2Offers telehealth

Dr. Gardith Joseph, MD
Oncologist
Brooklyn, NY, 11234
Next available: Apr 2Offers telehealth
Brooklyn, NY, 11234
Next available: Apr 2Offers telehealth
There are currently no additional providers matching this criteria

Dr. Steven Gruenstein, MD
Oncologist
4.80203 reviews
1 mi210 East 86th St, New York, NY, 10028
Â
4.80203 reviews
1 mi210 East 86th St, New York, NY, 10028
Â

Dr. Visaharan Sivasubramaniam, MD
Oncologist
5.0011 reviews
1.5 mi215 E 95th St, New York, NY, 10128
Â
5.0011 reviews
1.5 mi215 E 95th St, New York, NY, 10128
Â

Dr. Daniel Benasher, MD
Oncologist
4.85150 reviews
3 mi30-16 30th Dr, Long Island City, NY, 11102
Â
4.85150 reviews
3 mi30-16 30th Dr, Long Island City, NY, 11102
Â
More about Dr. Michael Tirgan, MD
Dr. Tirgan is the only physician in North America with a pure sub-specialty practice that is limited solely to the treatment of keloid patients. As of June 2020, Dr. Tirgan has treated over 1,700 keloid patients with all kinds of keloids. This includes not only adults but also very young children.
Dr. Tirgan's sub-specialty medical practice has attracted patients from every corner of the United States as well as patients from many other countries around the world.
Dr. Tirgan is an authority and an international leader in the non-surgical treatment of keloid patients. He is an avid researcher of keloid disorder and has published Several Peer-Reviewed Articles about his research as well as the proper treatment of keloids, including a comprehensive series of Keloid Treatment Guidelines to be used by other physicians.
Please take note that Dr. Tirgan does not participate with any insurance plans.
Education & experience
Education
Medical School - Tehran University of Medical Sciences School of Medicine, Doctor of Medicine
Atlantic City Medical Center, Residency in Internal Medicine
Practice
Michael H Tirgan, MD
Affiliation
Mount Sinai St. Luke’s
Mount Sinai Roosevelt
Certifications
American Board of Internal Medicine
Medical Oncology (Internal Medicine)
Awards and publications
DR TIRGAN'S MEDICAL PUBLICATIONS ABOUT KELOID Meeting Report: Clinical Challenge and Call for Research on Keloid Disorder The 3rd International Keloid Research Foundation Symposium, Beijing 2019., Uitto J, Tirgan M. J Invest Dermatol. 2019 Oct 16. pii: S0022-202X(19)33309-3. doi: 10.1016/j.jid.2019.10.002. KRF Clinical Practice Guidelines in Keloid Disorder (KRF Guidelines®) TREATMENT STRATEGY - Version 1.2019, Mar. 10, 2019. Journal of Keloid research. Special Edition, April 1, 2019 PUBIC KELOIDS - Version 1.2018, Mar. 10, 2019. Journal of Keloid research. Special Edition, April 1, 2019 CHEST KELOIDS - Version 1.2019, Jan. 29, 2019. Journal of Keloid research. Special Edition, April 1, 2019 MAGNETIC DISKS - Version 1.2019, Jan. 29, 2019. Journal of Keloid research. Special Edition, April 1, 2019 INTRA-LESIONAL CHEMOTHERAPY - Version 1.2018, Dec. 10, 2018. Journal of Keloid research. Special Edition, April 1, 2019 NECK KELOIDS - Version 1.2018, Dec. 10, 2018. Journal of Keloid research. Special Edition, April 1, 2019 FACE KELOIDS - Version 1.2018, Dec. 5, 2018. Journal of Keloid research. Special Edition, April 1, 2019 SCALP KELOIDS - Version 1.2018, Nov. 30, 2018. Journal of Keloid research. Special Edition, April 1, 2019 CRYOTHERAPY - Version 1.2018, Nov. 30, 2018. Journal of Keloid research. Special Edition, April 1, 2019 INTRA-LESIONAL TRIAMCINOLONE - Version 1.2018, Nov. 19, 2018. Journal of Keloid research. Special Edition, April 1, 2019 EAR KELOIDS - Version 1.2018, Nov. 19, 2018. Journal of Keloid research. Special Edition, April 1, 2019 Post Otoplasty Keloids–Case Series and Report of Successful Treatment with Cryotherapy. Keloid research. 2017 vol. 1 no. 1, July 1, 1-7 Ear Keloid Recurrence 13 Years after Adjuvant Radiation Therapy – Case Report. Keloid research. 2017 vol. 1 no. 1, July 1, 17-20 Intra-lesional Steroid Injections: Can they be harmful to some patients? Results of an online survey. International Journal of Keloid research. 2017 vol. 1 no. 1, July 1, 21-28 Aberrant connective tissue differentiation towards cartilage and bone underlies human keloids in African Americans. Fuentes-Duculan J, Bonifacio KM, Suárez-Fariñas M, Kunjravia N, Garcet S, Cruz T, Wang CQ, Xu H, Gilleadeau P, Sullivan-Whalen M, Tirgan MH, Krueger JG. Exp Dermatol. 2016 Dec 11 Massive ear keloids: Natural history, evaluation of risk factors and recommendation for preventive measures – A retrospective case seriesF1000 Research, October 13, 2016 Neck keloids: evaluation of risk factors and recommendation for keloid staging system, F1000 Research, June 28, 2016 Clinical Implications of Single- Versus Multiple-Site Keloid Disorder: A Retrospective Study in an Asian Population. Park TH, Park JH, Tirgan MH, Halim AS, Chang CH. Ann Plast Surg. 2014 Mar 28 (PMID: 24681623) Reply: Outcomes of surgical excision with pressure therapy using magnets and identification of risk factors for recurrent keloids. Park TH, Park JH, Tirgan MH, Chang CH. Plast Reconstr Surg. 2013 Oct;132(4):667e-668e. (PMID: 24076718) Nine-month-old patient with bilateral earlobe keloids. Tirgan MH, Shutty CM, Park TH., Pediatrics. 2013 Jan; 131(1):e313-7. (PMID: 23248221) Role of Surgery in Treatment of Keloid; Preliminary Results of an Online Survey. Abstract Accepted, AAD 2013 Worsening of Keloids after Intralesional Injections. Abstract Accepted, AAD 2013
Background
Languages spoken
English
Gender
Male
NPI number
#1922157973
Michael Tirgan does not participate in Zocdoc to offer online booking at this time
Similar providers on Zocdoc
Top-rated
Closest to you
Available today

Dr. Steven Gruenstein, MD
Oncologist
4.80203 reviews
1 mi12 E 86th St, New York, NY, 10028
Â
4.80203 reviews
1 mi12 E 86th St, New York, NY, 10028
Â

Dr. Gardith Joseph, MD
Oncologist
11.5 mi5202 Avenue N, Brooklyn, NY, 11234
Next available: Apr 2Offers telehealth
11.5 mi5202 Avenue N, Brooklyn, NY, 11234
Next available: Apr 2Offers telehealth

Dr. Gardith Joseph, MD
Oncologist
Brooklyn, NY, 11234
Next available: Apr 2Offers telehealth
Brooklyn, NY, 11234
Next available: Apr 2Offers telehealth
There are currently no additional providers matching this criteria

Dr. Steven Gruenstein, MD
Oncologist
4.80203 reviews
1 mi210 East 86th St, New York, NY, 10028
Â
4.80203 reviews
1 mi210 East 86th St, New York, NY, 10028
Â

Dr. Visaharan Sivasubramaniam, MD
Oncologist
5.0011 reviews
1.5 mi215 E 95th St, New York, NY, 10128
Â
5.0011 reviews
1.5 mi215 E 95th St, New York, NY, 10128
Â

Dr. Daniel Benasher, MD
Oncologist
4.85150 reviews
3 mi30-16 30th Dr, Long Island City, NY, 11102
Â
4.85150 reviews
3 mi30-16 30th Dr, Long Island City, NY, 11102
Â
Which hospital is Dr. Michael Tirgan affiliated with?
Dr. Michael Tirgan is affiliated with Mount Sinai St. Luke’s and Mount Sinai Roosevelt.
What practice does Dr. Michael Tirgan work with?
Dr. Michael Tirgan works with Michael H Tirgan, MD.
Where is Dr. Michael Tirgan's office located?
Dr. Michael Tirgan has 2 office locations in New York, view full addresses on Dr. Tirgan's profile.
Which board certifications does Dr. Michael Tirgan have?
Dr. Michael Tirgan is certified by American Board of Internal Medicine and Medical Oncology (Internal Medicine).
What languages does Dr. Michael Tirgan speak?
Dr. Michael Tirgan speaks English.